{"id":"telminuvo-tab-80-5mg","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4111629","moleculeType":"Small molecule","molecularWeight":"416.46"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Further research is needed to fully understand the mechanism of action of Telminuvo. It is likely that it works by interacting with a specific protein or receptor in the body.","oneSentence":"Telminuvo's mechanism of action is not well-documented, but it is believed to work by inhibiting a specific molecular target.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:37:51.474Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 3 for unspecified indication"}]},"trialDetails":[{"nctId":"NCT02358824","phase":"PHASE1","title":"CKD-828 (80/5mg) Pharmacokinetic Study","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2015-02","conditions":"Hypertension","enrollment":48},{"nctId":"NCT02250833","phase":"PHASE1","title":"CKD-828 (80/5mg) Pharmacokinetic Study","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2014-09","conditions":"Hypertension","enrollment":69},{"nctId":"NCT01983735","phase":"PHASE3","title":"Efficacy and Safety of TELMINUVO to Stage 2 Hypertension","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2014-01","conditions":"Hypertension","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TELMINUVO Tab."],"phase":"phase_3","status":"active","brandName":"TELMINUVO Tab. (80/5mg)","genericName":"TELMINUVO Tab. (80/5mg)","companyName":"Chong Kun Dang Pharmaceutical","companyId":"chong-kun-dang-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Telminuvo's mechanism of action is not well-documented, but it is believed to work by inhibiting a specific molecular target. Used for Phase 3 for unspecified indication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}